Exploring market-approved azoles as potential breast cancer therapeutics targeting the VEGFR-2 biotarget.

ABSTRACT:

SUBMITTER: Atta AM 

PROVIDER: S-EPMC12699035 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature